Warwick, R.I.-based Biomedical Structures LLC (BMS) and Sunnyvale, Calif.-based Modified Polymer Components (MPC) have merged with the aim of providing a complete range of value-added offerings to medical device original equipment manufacturers (OEMs). Boston-based Ampersand Capital Partners will be the majority shareholder in the merged company. For the time being, the two companies will continue to operate under their respective names and retain their separate headquarters.
BMS is a developer and manufacturer of biomedical textiles for implantable medical device and other advanced clinical applications targeted to the orthopedic, cardiovascular, general surgery, tissue engineering and regenerative medicine, and other medical markets; and offers particular know-how in biopolymer fabrication methods. Manufacturing capabilities include knitting, braiding, weaving and nonwoven technologies.
MPC is a designer and manufacturer of custom polymer components and assemblies for medical device OEMs. It uses its proprietary radio frequency heating process to mold and modify plastics and provide innovative manufacturing solutions, and offers prototype and small- and large-scale production programs. Capabilities include tipping, flaring, hole drilling, marker band placement, reinforced tubing, printing, electrode assembly and component-level assemblies.
"MPC's unique bonding technologies are enabling exciting developments with custom plastic components for medical devices and other related industries, and we are pleased to be joining the companies to expand both our offerings and theirs," said BMS CEO Dean Tulumaris, who will head the merged company. "By merging BMS and MPC, both companies will benefit from a bicoastal presence and extensive combined resources, without affecting our existing commitments or the established level of superior quality and seamless operational efficiency our valued customers and employees have come to expect."
Added MPC CEO Mike Taylor, who will serve as chief technical officer of the combined company, "With our joint capabilities, we will be a more robust organization that will bring greater value to customers with a wider variety of needs, both related to custom plastics components and medical textiles."
